The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
It’s hard to be positive but here goes
On a more positive note at least we are only down 2.7% today ... could be worse
I was expecting the next news to be the about the patent but that has now been delayed again. Tim said value in 12 months approx 9 months ago. He's been burnt before with his predictions so I firmly believe there is something coming or he wouldn't have said it. Will he meet the deadline he set? I don't know.
I might come across as negative, i'm not i'm still bullish about SAR. The only reservations I have is the funding thing, will we get funding before we have to raise again? and that our compounds are just OK. I honestly believe if they were blockbusters we'd have a deal already. I think we are going to have to wrestle them through the trials and over the line which is fine as long as there is a steady rise in SP and we are funded.
Hi Ahfam to me that looks down the road, hopefully other drivers that Iamhappy summarized the other day, ie longterm toxicology study’s, IND application, SRRA results for SRA737 or a partner etc!
Yes, I did say Jan to mid-Feb pending patent grant which I believe will be the trigger, however, the patent hasn't happened yet. I still believe patent will be the trigger though as most majors want strong patents it's essentially where the money is- they can then price it as they please for the duration of said patent and whistle all the way to the bank.
Thanks Ahf
So why have your time lines changed. I’m pretty sure you predicted some major price increases in jam or feb but nothing has happened
*That should have read like trees shed leaves in Autumn but I think you all get the gist. Incidentally I have been invested since at least 2009 if not earlier it's been such a while I've forgotten but like everyone else I am keen to see some return on my money.
Utah, it's not that we try to slay the negative outlook. Look we all know the reality of AIM it can go either way it's a big risk as we have seen with Val, IMM, Summ etc. But what I think people are forgetting is that Tyk2 has become complicated as in more valuable since the Celgene deal last year which really put a focus on the market. So when Aber mentions why BMS just don't just secure a deal- what we have to remember is that Pfizer are also in the mix having already tested Tofa against our Tyk2 for some years- so it could be that they may have first refusal on a deal, maybe they want to take both cancer and auto-immune hence why they have been selling compounds last year to get cash in the coffers. We all now know that the market is massive for Ty2 and Jaks and there a real buzz and excitement about it. So I presume more than one major will be interested as most are losing patents on existing pipelines like trees in Autumn they will be anxious to secure a market set to thrive for the next 20-30yrs.
Cold fish pie - well said!
Yes aber you have the right....i think all holders here do.
The vast majority of posters have been here over 5 year, most around 10 and some over 12 and we have had the tough times, especially during the YA era....well it was for me:).
In some ways its just as tough now because it seems we are in a bit of limbo with big dark clouds hanging over is.
Nothing of any positivity is coming from the company and its a bit worrying because they must have some idea with whats happening by now....i hope they are not planning a bundled up interim because it wont wash.
The agm statement was pure pants....so if they dont have any positive movement to report, i will have expected them to sort out the tax issue (clarification) and issue a statement to confirm that salaries (100%) will be converted at the prevailing mid each month.
The bod need to man up and come to the table with a compromise for shareholders...they have been well paid and will have big pensions too look forward too after 15 years of sar.
So lets see the colour of your commitment reader and mitchell....its time to stop hiding behind the 'nothing to report' agenda.
The time is now and the floor is yours...are you in/out or just shaking it about because we are all fed up with this hokey cokey:)
What makes me laugh Ab is that this board is awash with positive people who slay negative people and predict fantastic things . The most recent was for great things jan and feb. well jan has passed and feb is passing and f all has happened to price. So they either talk total crap, are purposely deceitful or just like everyone else no bugger but just for personal reasons have more time on their hands. I quipped about change of name to pharma and immune but I half expect a name change
Hi aber. That is a very fair assessment and something which I have thought off as well. Fingers crossed we all get put out of our misery soon. Am positive here but been here since 2009 and understand pharmaceutical industry is slow and evidence based so hopefully our tyk 3 data will speak for itself
As a LTHER I think I have earned the right to be a little negative and concerned as the comms is as poor as it was prior to the AGM ... I will become more positive when I see some reason in that direction but currently I cannot stop thinking of the following -ve scenario
I am the CEO of BMS and ahead of me is a 30 billion pound per year market .. I have only one possible company with a better compound (or do I) - if I do what do I do - I offer to buy them out for 50,100 or 200 million pounds to secure my future £30B stake .... so why no offer ? Are we all wrong ?
Therefore I need the BOD to provide some reassurances via comma .. maybe then I will become a happy chappie .. and richer
Blimey there’s some bull**** negativity on here for no reason whatsoever.
Lighten up folks